
Polyplus Introduces Transgene Plasmid Engineering Services for optimized Viral Vector Manufacturing
Strasbourg, France, 2 August 2022 – Polyplus, a leading upstream solutions provider for advanced biologic and cell and gene therapy production from research to commercial